Tidal Investments LLC Grows Stock Holdings in Danaher Co. (NYSE:DHR)

Tidal Investments LLC increased its stake in shares of Danaher Co. (NYSE:DHR) by 43.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 75,704 shares of the conglomerate’s stock after buying an additional 22,757 shares during the quarter. Tidal Investments LLC’s holdings in Danaher were worth $17,378,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter valued at about $27,000. Golden State Wealth Management LLC acquired a new stake in Danaher in the fourth quarter valued at about $31,000. Hurley Capital LLC acquired a new stake in Danaher in the fourth quarter valued at about $34,000. Pineridge Advisors LLC lifted its position in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares during the period. Finally, Rialto Wealth Management LLC acquired a new stake in shares of Danaher during the 4th quarter valued at approximately $34,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 2.7%

DHR stock opened at $196.03 on Monday. The stock has a market capitalization of $140.29 billion, a P/E ratio of 37.13, a PEG ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a one year low of $171.00 and a one year high of $281.70. The company has a 50 day moving average price of $196.87 and a two-hundred day moving average price of $217.27.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher’s dividend payout ratio is presently 24.85%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on DHR. Jefferies Financial Group reduced their price target on shares of Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research report on Tuesday, April 22nd. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Royal Bank of Canada reiterated an “outperform” rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. The Goldman Sachs Group reduced their price target on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a research report on Wednesday, April 23rd. Finally, Wells Fargo & Company dropped their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $264.40.

Insider Activity

In other news, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at $3,005,442. The trade was a 51.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman now directly owns 3,105,808 shares of the company’s stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.